Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 results

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported Q4 revenue for the quarter at $27.91 million versus the consensus estimate of $24.65 million.

For earnings history and earnings-related data on Mirum Pharmaceuticals, Inc. (MIRM) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• General Mills (GIS) PT Lowered to $42 at Freedom Broker
• Isabella Bank added to Russell 2000 index after Nasdaq listing